NCT00006178View on ClinicalTrials.gov

Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Kidney Failure
Interventions
DRUG

Sirolimus

DRUG

Thymoglobulin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006178 - Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection | Biotech Hunter | Biotech Hunter